- Home
- JAGX vs NUWE Comparison
JAGX vs NUWE Comparison
Compare JAGX & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- NUWE
- Stock Information
- Founded
- JAGX 2013
- NUWE 1999
- Country
- JAGX United States
- NUWE United States
- Employees
- JAGX N/A
- NUWE N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- JAGX Health Care
- NUWE Health Care
- Exchange
- JAGX Nasdaq
- NUWE Nasdaq
- Market Cap
- JAGX 3.4M
- NUWE 3.9M
- IPO Year
- JAGX N/A
- NUWE N/A
- Fundamental
- Price
- JAGX $2.40
- NUWE $6.90
- Analyst Decision
- JAGX Strong Buy
- NUWE Strong Buy
- Analyst Count
- JAGX 1
- NUWE 1
- Target Price
- JAGX $60.00
- NUWE $714.00
- AVG Volume (30 Days)
- JAGX 98.6K
- NUWE 200.5K
- Earning Date
- JAGX 08-12-2025
- NUWE 08-12-2025
- Dividend Yield
- JAGX N/A
- NUWE N/A
- EPS Growth
- JAGX N/A
- NUWE N/A
- EPS
- JAGX N/A
- NUWE N/A
- Revenue
- JAGX $11,552,000.00
- NUWE $8,787,000.00
- Revenue This Year
- JAGX $22.41
- NUWE $6.53
- Revenue Next Year
- JAGX $30.00
- NUWE $51.63
- P/E Ratio
- JAGX N/A
- NUWE N/A
- Revenue Growth
- JAGX 13.93
- NUWE N/A
- 52 Week Low
- JAGX $2.28
- NUWE $6.33
- 52 Week High
- JAGX $110.75
- NUWE $196.98
- Technical
- Relative Strength Index (RSI)
- JAGX 29.42
- NUWE 27.27
- Support Level
- JAGX $2.28
- NUWE $6.33
- Resistance Level
- JAGX $2.79
- NUWE $7.82
- Average True Range (ATR)
- JAGX 0.16
- NUWE 0.93
- MACD
- JAGX 0.11
- NUWE 0.74
- Stochastic Oscillator
- JAGX 16.00
- NUWE 11.28
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.